chr7-75422171-G-A
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_001099415.3(POM121C):c.2081C>T(p.Pro694Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000502 in 1,606,842 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001099415.3 missense
Scores
Clinical Significance
Conservation
Publications
- schizophreniaInheritance: Unknown Classification: NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| POM121C | ENST00000615331.5 | c.2081C>T | p.Pro694Leu | missense_variant | Exon 13 of 15 | 1 | NM_001099415.3 | ENSP00000481575.1 | ||
| POM121C | ENST00000607367.5 | c.2807C>T | p.Pro936Leu | missense_variant | Exon 11 of 13 | 5 | ENSP00000476236.2 |
Frequencies
GnomAD3 genomes AF: 0.000302 AC: 46AN: 152096Hom.: 0 Cov.: 28 show subpopulations
GnomAD2 exomes AF: 0.000304 AC: 34AN: 111942 AF XY: 0.000423 show subpopulations
GnomAD4 exome AF: 0.000522 AC: 760AN: 1454628Hom.: 0 Cov.: 34 AF XY: 0.000545 AC XY: 394AN XY: 723024 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000302 AC: 46AN: 152214Hom.: 0 Cov.: 28 AF XY: 0.000296 AC XY: 22AN XY: 74426 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.2081C>T (p.P694L) alteration is located in exon 13 (coding exon 10) of the POM121C gene. This alteration results from a C to T substitution at nucleotide position 2081, causing the proline (P) at amino acid position 694 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at